• Ivermectin is a potent prescription drug used primarily to treat parasitic infections in humans and animals.

  • This drug disrupts nerve impulses and muscle function in parasites - and eventually they die.

  • In 2020, when the COVID-19 pandemic began, scientists began an urgent search for a cure for the disease. There was no time to develop a new drug, so researchers hoped that an existing drug would have additional properties that would be useful in fighting the coronavirus. One of the drugs that came up as potentially effective in COVID-19 was stromectol.

  • Computer simulations showed that ivermectin can inhibit the enzyme responsible for duplicating the viral genome in infected cells.

Buy ivermectin 3 mg without prescription

Stromectol 12mg usa

Beautiful Websites

And some laboratory experiments on infected cells have demonstrated that this drug prevents the coronavirus from transferring its genetic material into the nucleus of the host cell.

Read more

Responsive Layout

All this prevents the coronavirus from creating new viral particles.

Read more

Awesome Logos

This article is about coronavirus disease, or COVID-19. In all articles about coronavirus disease, we take the position of the World Health Organization, or WHO.

Read more

High Res Prints

A safe dose of ivermectin, at which it destroys parasites but is not harmful to health, is 150-200 mcg per kilogram of weight.

Read more

Our Latest Work

Lorem Website

However, animal experiments have shown that one tablet of ivermectin does not reach the concentration at which the drug is able to act effectively on coronaviruses. Two pills are not enough either.

Ipsum Logo

Even when scientists took a huge dose of 120 mg, the concentration of ivermectin in the lungs was still half what was needed for the therapeutic effect.

Dolor Prints

Although there is little conclusive evidence in favor of ivermectin, the drug is available in many countries and is inexpensive.

Sit Amet Website

Therefore, in Latin American states, ivermectin is widely used to treat COVID-19.


In July 2021, a team of researchers from the Cochrane Collaboration, an international organization of scientists that professionally verifies evidence, analyzed the data.

The researchers concluded that too few people participated in most of the experiments and that, in general, the experiments were not of the highest quality. Nevertheless, they selected 14 of the highest quality studies and summarized their results.

It turned out that ivermectin, when compared to placebo, had practically no effect on the patients' well-being after 14 or 28 days after the start of treatment.

It also reduces the number of complications and decreases the amount of time you spend in the hospital.